Skip to main content
Log in

ICERs for diagnostics and factors impacting NICE decisions

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Chen G, et al. Evaluation of the National Institute for Health and Care Excellence Diagnostics Assessment Program Decisions: Incremental Cost-Effectiveness Ratio Thresholds and Decision-Modifying Factors. Value in Health : 18 Aug 2020. Available from: URL: https://doi.org/10.1016/j.jval.2020.04.1835

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

ICERs for diagnostics and factors impacting NICE decisions. PharmacoEcon Outcomes News 861, 19 (2020). https://doi.org/10.1007/s40274-020-7101-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-020-7101-1

Navigation